Equities

Valiant Laboratories Ltd

VALIANTLAB:NSI

Valiant Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)119.77
  • Today's Change-0.63 / -0.52%
  • Shares traded84.36k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(7.7)381302
Depreciation/depletion201616
Non-Cash items0.78(0.07)(4.65)
Cash taxes paid, supplemental(9.82)8877
Cash interest paid, supplemental0.780.250.24
Changes in working capital6.12164(166)
Total cash from operations19561148
INVESTING
Capital expenditures(459)(377)(59)
Other investing and cash flow items, total(980)(175)(95)
Total cash from investing(1439)(552)(154)
FINANCING
Financing cash flow items(0.78)(0.25)(0.58)
Total cash dividends paid------
Issuance (retirement) of stock, net1,359--489
Issuance (retirement) of debt, net167(9.09)(281)
Total cash from financing1,524(9.34)208
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash105(0.51)201
Net cash-begin balance/reserved for future use13130
Net cash-end balance/reserved for future use11713201
SUPPLEMENTAL INCOME
Depreciation, supplemental201616
Cash interest paid, supplemental0.780.250.24
Cash taxes paid, supplemental(9.82)8877
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.